Generic for Corlanor: Ivabradine

Yes. The generic name for Corlanor is ivabradine. 6 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 2 of the 3 Corlanor products the Orange Book lists.

Run it in Rivvi

Map Corlanor and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Corlanor products in the Orange Book

Corlanor products and approved generics
Form and route	Strength	Brand status	Brand TE	Active generics	Generic TE codes
solution, oral	5MG/5ML (1MG/ML)	Discontinued	None	0	None
tablet, oral	EQ 5MG BASE	Discontinued	None	6	AB
tablet, oral	EQ 7.5MG BASE	Discontinued	None	6	AB

NDA 209964, 206143, held by AMGEN INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic ivabradine

Approved generic versions of Corlanor
Company	ANDA	TE code	Approved	Strengths
INGENUS PHARMACEUTICALS LLC	214051	AB (A-rated, therapeutically equivalent)	December 30, 2021	EQ 5MG BASE, EQ 7.5MG BASE
ANNORA PHARMA PRIVATE LTD	213366	AB (A-rated, therapeutically equivalent)	October 5, 2022	EQ 5MG BASE, EQ 7.5MG BASE
ZYDUS PHARMACEUTICALS USA INC	213442	AB (A-rated, therapeutically equivalent)	November 29, 2023	EQ 5MG BASE, EQ 7.5MG BASE
BIONPHARMA INC	213276	AB (A-rated, therapeutically equivalent)	September 5, 2024	EQ 5MG BASE, EQ 7.5MG BASE
ALEMBIC PHARMACEUTICALS LTD	215238	AB (A-rated, therapeutically equivalent)	November 8, 2024	EQ 5MG BASE, EQ 7.5MG BASE
MSN LABORATORIES PRIVATE LTD	213483	AB (A-rated, therapeutically equivalent)	April 28, 2025	EQ 5MG BASE, EQ 7.5MG BASE

Corlanor patents

Patents listed for Corlanor
Patent	Expires	Covers	Use code	NDA
7361650	February 22, 2026	Drug substance, Drug product	U-1694	209964
7361649	February 22, 2026	Drug substance, Drug product	U-1694	209964
7879842	February 22, 2026	Drug substance, Drug product	U-1694	209964
7879842*PED	August 22, 2026	Method of use	None	206143
7361649*PED	August 22, 2026	Method of use	None	206143
7361650*PED	August 22, 2026	Method of use	None	206143
7867996	December 12, 2026	Drug substance, Drug product	U-1694	209964
7867996*PED	June 12, 2027	Method of use	None	206143

Corlanor exclusivity

Exclusivity listed for Corlanor
Code	Meaning	Expires	NDA
ODE-234	Orphan drug exclusivity	April 22, 2026	209964
PED	Pediatric exclusivity	October 22, 2026	209964

Corlanor NDC codes

Questions

Is there a generic for Corlanor?

Yes. The generic name for Corlanor is ivabradine. 6 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 2 of the 3 Corlanor products the Orange Book lists.

What is the generic name for Corlanor?

The active ingredient in Corlanor is ivabradine, per the FDA Orange Book.

When does the Corlanor patent expire?

The last patent listed for Corlanor in the Orange Book expires June 12, 2027. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

Generic for Corlanor